These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 36805440)
1. Identification of G protein subunit alpha i2 as a promising therapeutic target of hepatocellular carcinoma. Chen M; Li Z; Gu C; Zheng H; Chen Y; Cheng L Cell Death Dis; 2023 Feb; 14(2):143. PubMed ID: 36805440 [TBL] [Abstract][Full Text] [Related]
2. G protein inhibitory α subunit 2 is a molecular oncotarget of human glioma. Wang Y; Liu F; Wu J; Zhang MQ; Chai JL; Cao C Int J Biol Sci; 2023; 19(3):865-879. PubMed ID: 36778118 [TBL] [Abstract][Full Text] [Related]
3. Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma. Yin DP; Zhang H; Teng H; Zhang D; Chen P; Xie L; Liu JS Cell Death Dis; 2023 Dec; 14(12):792. PubMed ID: 38049415 [TBL] [Abstract][Full Text] [Related]
4. G protein subunit alpha i2's pivotal role in angiogenesis. Bai CW; Lu L; Zhang JN; Zhou C; Ni YC; Li KR; Yao J; Zhou XZ; Lan CG; Cao C Theranostics; 2024; 14(5):2190-2209. PubMed ID: 38505600 [TBL] [Abstract][Full Text] [Related]
5. HBO1 overexpression is important for hepatocellular carcinoma cell growth. Zhong W; Liu H; Deng L; Chen G; Liu Y Cell Death Dis; 2021 May; 12(6):549. PubMed ID: 34039960 [TBL] [Abstract][Full Text] [Related]
6. The lncRNA Zhou N; Li S; Wu D; Zhang F; Tang F; Li Y DNA Cell Biol; 2021 Oct; 40(10):1278-1289. PubMed ID: 34558987 [TBL] [Abstract][Full Text] [Related]
7. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth. Zheng L; Liang P; Li J; Huang XB; Liu SC; Zhao HZ; Han KQ; Wang Z PLoS One; 2012; 7(9):e45412. PubMed ID: 23049798 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Yao J; Liang L; Huang S; Ding J; Tan N; Zhao Y; Yan M; Ge C; Zhang Z; Chen T; Wan D; Yao M; Li J; Gu J; He X Hepatology; 2010 Mar; 51(3):846-56. PubMed ID: 20054866 [TBL] [Abstract][Full Text] [Related]
9. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway. Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374 [TBL] [Abstract][Full Text] [Related]
10. The zinc finger protein GATA4 induces mesenchymal-to-epithelial transition and cellular senescence through the nuclear factor-κB pathway in hepatocellular carcinoma. Xiang Q; Zhou D; He X; Fan J; Tang J; Qiu Z; Zhang Y; Qiu J; Xu Y; Lai G J Gastroenterol Hepatol; 2019 Dec; 34(12):2196-2205. PubMed ID: 30995348 [TBL] [Abstract][Full Text] [Related]
11. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo. Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma cells downregulate NADH:Ubiquinone Oxidoreductase Subunit B3 to maintain reactive oxygen species homeostasis. Zhang Z; Zhao Q; Wang Z; Xu F; Liu Y; Guo Y; Li C; Liu T; Zhao Y; Tang X; Zhang J Hepatol Commun; 2024 Mar; 8(3):. PubMed ID: 38437062 [TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. Frau M; Feo F; Pascale RM J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184 [TBL] [Abstract][Full Text] [Related]
14. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma. Tian F; Cai D Gene; 2022 Jan; 807():145964. PubMed ID: 34530087 [TBL] [Abstract][Full Text] [Related]
15. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth. Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803 [TBL] [Abstract][Full Text] [Related]
16. Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells. Chen J; Li X; Cheng Q; Ning D; Ma J; Zhang ZP; Chen XP; Jiang L J Cell Biochem; 2018 Feb; 119(2):2368-2380. PubMed ID: 28885717 [TBL] [Abstract][Full Text] [Related]
17. EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β-catenin signaling. Li Z; Xue TQ; Yang C; Wang YL; Zhu XL; Ni CF J Cell Biochem; 2018 Dec; 119(12):10327-10337. PubMed ID: 30129142 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983 [TBL] [Abstract][Full Text] [Related]
19. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53. Cao P; Yang A; Wang R; Xia X; Zhai Y; Li Y; Yang F; Cui Y; Xie W; Liu Y; Liu T; Jia W; Jiang Z; Li Z; Han Y; Gao C; Song Q; Xie B; Zhang L; Zhang H; Zhang J; Shen X; Yuan Y; Yu F; Wang Y; Xu J; Ma Y; Mo Z; Yu W; He F; Zhou G Gastroenterology; 2018 Aug; 155(2):542-556. PubMed ID: 29702115 [TBL] [Abstract][Full Text] [Related]
20. RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma. Wang W; Jia WD; Hu B; Pan YY Oncotarget; 2017 Apr; 8(16):26434-26447. PubMed ID: 28460436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]